Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/1999
12/01/1999EP0959781A1 Improved tissue destruction in cryosurgery by use of thermal hysteresis proteins
12/01/1999EP0959682A1 Therapeutic and diagnostic applications of laminin and laminin-derived protein fragments
12/01/1999EP0833646B1 Multi-tyrosinated somatostatin analogs
12/01/1999EP0831773B1 Peptide/protein suspended formulations
12/01/1999EP0667782B1 Reconstituted platelet membrane vesicles
12/01/1999EP0582631B1 Use of S-nitrosothiols for the preparation of a medicament for the relaxation of smooth muscle
12/01/1999CN1237209A Herpesvirus saimiri as viral vector
12/01/1999CN1236645A Medicine composition containing osteoinductive protein and dorsalizing factor
11/1999
11/30/1999US5994618 Growth differentiation factor-8 transgenic mice
11/30/1999US5994537 Process for preparing azepinone compounds useful in the inhibition of ACE and NEP
11/30/1999US5994523 A nucleic acid molecule encoding a peptide comprising a sequence consisting of 8 contiguous amino acids of th mart-1(melanoma antigen recognized by t-cell-1) a preferential amino acid sequence which is capable of reacting tumor
11/30/1999US5994522 Recombinant nucleic acid encoding a b cell linker protein
11/30/1999US5994519 Labelling proteins, peptides, or ligands by binding first marker ligand-enzyme conjugate to a specific binding pair member; binding label molecules to proteins, peptides, or ligands; isolating and/or purifying labelled product
11/30/1999US5994518 Method of producing a polypeptide having human granulocyte colony stimulating factor activity
11/30/1999US5994515 Antibodies directed against cellular coreceptors for human immunodeficiency virus and methods of using the same
11/30/1999US5994514 Differential binding fc epsilon ri antagonist ige polypeptide
11/30/1999US5994513 Oncoprotein protein kinase
11/30/1999US5994511 Anti-IgE antibodies and methods of improving polypeptides
11/30/1999US5994510 Recombinant antibodies specific for TNFα
11/30/1999US5994506 An isolated polypeptide comprising at least 50 contiguous amino acid residues
11/30/1999US5994505 Forms of class II MHC transactivator (CIITA)
11/30/1999US5994503 Nucleotide and protein sequences of lats genes and methods based thereon
11/30/1999US5994502 Inhibitors of oligosaccharyl transferase
11/30/1999US5994501 Hybrid protein having cell adhesive properties which includes a specific amino acid sequence from fibronectin; for promoting or suppressing cell attachment to a substrate; for enhancing phagocytic activity of cells
11/30/1999US5994500 Antagonists of intestinotrophic GLP-2 peptides
11/30/1999US5994392 Antipsychotic prodrugs comprising an antipsychotic agent coupled to an unsaturated fatty acid
11/30/1999US5994372 Peripherally active anti-hyperalgesic opiates
11/30/1999US5994361 Antitumor, anticancer agent
11/30/1999US5994341 Anti-angiogenic Compositions and methods for the treatment of arthritis
11/30/1999US5994339 Oxidant scavengers
11/30/1999US5994338 Stabilized pharmaceutical compositions, with quinupristine and dalfopristine base and their preparation
11/30/1999US5994328 Hypoestoxides, derivatives and agonists thereof for use as anticancer agents
11/30/1999US5994325 Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers
11/30/1999US5994320 Antisense oligonucleotides and methods for treating central nervous system tumors
11/30/1999US5994319 Synergistic mixture
11/30/1999US5994318 Complex; administering biologically active material
11/30/1999US5994317 Quaternary cytofectins
11/30/1999US5994315 Low adenosine agent, composition, kit and method for treatment of airway disease
11/30/1999US5994313 Regulated apoptosis
11/30/1999US5994312 Peptidyl compounds
11/30/1999US5994311 Using a oligopeptides, polypeptide
11/30/1999US5994310 Binding
11/30/1999US5994309 Anti-invasive and anti-angiogenic compositions and methods
11/30/1999US5994308 Bactericides; fungicides
11/30/1999US5994307 Human t-cell lymphoma virus
11/30/1999US5994306 Fine-tuned protegrins
11/30/1999US5994305 Calibration of test compound
11/30/1999US5994304 Polypeptide
11/30/1999US5994303 Use of insulin and IGF-I
11/30/1999US5994302 Human vascular IBP-like growth factor
11/30/1999US5994301 Corpuscles of stannius protein, stanniocalcin
11/30/1999US5994300 Vascular endothelial cell growth factor C subunit
11/30/1999US5994299 Cyclosporin compounds, their preparation and the pharmaceutical compositions which contain them
11/30/1999US5994298 Proteins for cancer cell specific induction of apoptosis and method for isolation thereof
11/30/1999US5994297 Therapy for Staphylococcus aureus
11/30/1999US5994296 Human mutant tissue factor compositions useful as tissue factor antagonists
11/30/1999US5994294 Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses
11/30/1999US5994293 Peptidyl compounds and their therapeutic use
11/30/1999US5994292 Interferon-inducible protein 10 is a potent inhibitor of angiogenesis
11/30/1999US5994131 Incubating a test compound with epithial cells that will express the human op-1 protein, which induces endochondral bone formation; measuring amount of protein expressed from cells with test compound, comparing values to control cells
11/30/1999US5994130 Multidrug resistance-associated polypeptide
11/30/1999US5994127 In vivo production and delivery of erythropoietin or insulinotropin for gene therapy
11/30/1999US5994125 A synthetic oligonucleotide; anticoagulant, hypertensive agent, antiinflammatory agent,
11/30/1999US5994124 A protein specific to target rnas; therapy for human immunodeficiency virus
11/30/1999US5994119 Mammalian regulator of nonsense-mediated RNA decay
11/30/1999US5994112 A polynucleotide which codes a protein; antiproliferative agents, anticarcinogenic agents, antiinflammatory agents
11/30/1999US5994111 A polypeptide; treatment and diagnosis of respiratory infections, septic arthritis, cardiovascular infections, gastrointestinal infections, toxic shock syndrome; antibiotics
11/30/1999US5994109 Nucleic acid transporter system and methods of use
11/30/1999US5994108 A human enbryonic kidney cell line which produces increased levels of the human immunodefiency virus mutant stem-loop rna structure in the presence of a transactivation protein; vaccines for human immunodefiency virus
11/30/1999US5994106 Stocks of recombinant, replication-deficient adenovirus free of replication-competent adenovirus
11/30/1999US5994104 Interleukin-12 fusion protein
11/30/1999US5994101 DNA encoding gidA1 polypeptides
11/30/1999US5994100 HAS2 splicing variant HOEFC11: a target in chronic renal failure, inflammatory diseases and myocardial ischemia
11/30/1999US5994098 G protein coupled receptor gene; treatment of pain, diabetes, eating disorders, asthma; hypotensive/hypertensive agents; parkinson's/huntington's/cardiovascular diseases, ulcers, anticarcinogenic/antiallergens agents; osteoprosis,
11/30/1999US5994097 Polynucleotide encoding human G-protein coupled receptor
11/30/1999US5994096 Regulator
11/30/1999US5994094 A bone morphogenetic protein; treatment of osteoporosis, prevent transplant rejection; wound healing agents; regeneration of bones, cartilage, connective tissue, skin, mucous membranes, epithelium and teeth
11/30/1999US5994088 Treating cells with a glycoprotein substrate from a group; reserpine, gramicidin, cyclosporine, vincristine, actinomycin d, taxol, verapamil and vinblastine; reacting cells with antibody to glycoprotein/substrate, detect increase binding
11/30/1999US5994082 Methods for the identification of inhibitors which suppress the activity of proteins displaying CIITA activity
11/30/1999US5994070 A nucleic acid and polypeptide which regulates a variety of cellular processes; diagnosis and treatment of nervous sytem disorders; alzheimer's/huntinton's/parkinson's diseases
11/30/1999US5994060 Gro genes, proteins, and uses thereof
11/30/1999US5994055 HIV trans-activator Tat binding to CDK7 and activation of CTD phosphorylation
11/30/1999US5994054 Creating an expression library, transfecting cells with a dna molecule which contains a long terminal repeat promoter sequence of human immunodeficiency virus adjacent to a reporter molecule, measuring viricide activity
11/30/1999US5993889 Trehalose phosphorylase, its preparation and use
11/30/1999US5993863 Contains sugars, amino acids, electrolytes and a fat emulsion at a specific mixing ratio and has a specific ph value and a titratable acidity.
11/30/1999US5993855 Microspheres prepared by emulsifying an aqueous phase containing a drug and an oil phase containing a biodegradable polylactide to form a w/o emulsion, and then mixing and agitating this emulsion with another aqueous phase to form a
11/30/1999US5993845 Histone deacetylase inhibitor and a pharmaceutically acceptable carrier wherein the composition comprises from 0.05 to 100 mg of the histone deacetylase inhibitor.
11/30/1999US5993841 Treating or disorder of the nervous system comprising topically applying an antibiotic; an antihistamine; and a carrier; wherein said antibiotic and said antihistamine are present in relative amounts of 30:70 to 70:30% by weight
11/30/1999US5993828 Administering to the subject an effective dose of a composition comprising inactivated tumor cells having urinary tumor associated antigen on the cell surface and at least one tumor associated antigen
11/30/1999US5993826 Relates generally to various outer membrane proteins (omps) of moraxella catarrhalis for use as targets in immunotherapy
11/30/1999US5993821 Antigens and vaccines containing said vlps that may be effective in treatment of infections caused by such viruses.
11/30/1999US5993820 The antigenic sequence is inserted into the ltb molecule by inserting the gene encoding the inhibin fragment into etxb at the unique sma i restriction site.
11/30/1999US5993818 Use of autoantibodies for tumor therapy and prophylaxis
11/30/1999US5993817 Method to ameliorate osteolysis and metastasis
11/30/1999US5993816 Methods to inhibit humoral immune responses, immunoglobulin production and B cell activation with 5c8-specific antibodies
11/30/1999US5993814 Agents for inhibition of chemoattractant
11/30/1999US5993813 Family of high affinity, modified antibodies for cancer treatment
11/30/1999US5993811 Method and compositions for preventing and treating the systemic inflammatory response syndrome including sepsis
11/30/1999US5993810 Method of softening or ripening the cervix of a female mammal using collagenase
11/30/1999US5993809 The method and composition eliminates problems associated with conventional antibiotic treatments, such as inefficacy and promotion of antibiotic resistant bacterial strains.
1 ... 2449 2450 2451 2452 2453 2454 2455 2456 2457 2458 2459 2460 2461 2462 2463 2464 2465 2466 2467 2468 2469 ... 3163